Ascentage Pharma Group International
Ascentage Pharma Group International (6855.HK) Stock Forecast & Price Predictions
Get the latest Ascentage Pharma Group International (6855.HK) stock forecast across short-term and long-term horizons. Meyka AI generates price predictions using advanced models trained on historical data. These forecasts are not investment advice but directional insights to help investors and traders plan strategies.
Model Information
The Forecast Prediction Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerMonthly Forecast
Quarterly Forecast
Yearly Forecast
3 Years Forecast
5 Years Forecast
7 Years Forecast
Ascentage Pharma Group International Stock Forecast Summary
Ascentage Pharma Group International (6855.HK) stock is currently priced at $37.56. Based on Meyka AI predictions, the short-term outlook is bullish, with momentum pointing higher. The 1-month projection suggests a move toward $46.39.
In the long term, 6855.HK shows a bullish trend. The 2027 forecast points to $84.52 (125.02% change), while the 2031 forecast suggests $168.53 (348.70% change). Looking 7 years ahead, projections estimate the stock could trade near $207.37, a 452.10% change from today’s price.
Bullish
Bullish
Bullish
This mix indicates that Ascentage Pharma Group International stock is expected to rise steadily over the coming years.
Investment Calculator
Estimate your potential returns on 6855.HK using our advanced Investment Calculator with AI-driven price forecasts. Enter your investment amount and select a target date to view expected results, including estimated profit, loss, and ROI performance.
Based on your investment of HK$1,000.00 in Ascentage Pharma Group International and holding until June 2nd, 2027, you could face a potential +HK$1,250.17 profit, reflecting a +125.0% ROI over the next 365 days. These projections help you better understand short-term market movements.
$Shares Bought
26.6241
@ HK$37.56/share
~Forecast Price
HK$84.52
1-year AI forecast
$Est. Portfolio Value
HK$2,250.17
+HK$1,250.17 profit
%ROI
+125.0%
return on investment
Ascentage Pharma Group International yearly Price Forecast Chart
Explore the yearly forecast chart for 6855.HK, which maps expected price movement, support levels, and resistance targets. The dropdown lets you view forecasts across multiple horizons, from short-term daily trends to 7-year projections, helping investors evaluate Ascentage Pharma Group International over different timeframes.
No forecast data available
No prediction data found for this time period.
Forecasting data is not available for 6855.HKForecasting details for 6855.HK are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.Ascentage Pharma Group International Stock Forecast 2026
The forecast for Ascentage Pharma Group International (6855.HK) in 2026 suggests a price of $84.52, representing a 125.02% move from today’s price.
Average Target: $84.52
Market Outlook: bullish based on current trend indicators.
Key Drivers in 2026:- Earnings growth projections.
- Competitive performance in the Healthcare.
- Macroeconomic factors such as interest rates and inflation.
Ascentage Pharma Group International Stock Forecast 2030
By 2030, Meyka AI projects 6855.HK could trade near $168.53, showing a potential 348.70% compared to current levels.
Average Target: $168.53
Market Outlook: bullish.
What could influence the 2030 forecast:- Technological innovation and product cycles.
- Expansion into global markets.
- Long-term investor sentiment toward Ascentage Pharma Group International.
Ascentage Pharma Group International 7-Year Stock Forecast (2032–2033)
Looking 7 years ahead, the long-term forecast for 6855.HK points to a price around $207.37, which is a projected 452.10% move from today’s level.
Average Target: $207.37
Outlook: bullish, depending on macroeconomic conditions and sector growth.
Long-Term Drivers:- Global economic expansion or contraction.
- Regulatory and policy environment.
- Ascentage Pharma Group International’s ability to maintain market leadership.